Vaccines

News Vaccines

• Radio chip and sensor in one

  RFID technology is on the advance. But, up to now radio chips primarily supply data for the identification of products. Researchers have now developed a transponder which measures temperature, pressure and humidity. The chip with sensor function could revolutionize the applications market. »Special more

• Energy-autonomous sensors in logistics: continuous control of perishable goods

  The safety and quality in the food supply of today’s globally organized and networked supply chain is everything else than warranted. More than 50% of all foodstuffs are spoiled in the transport routes; alone in Great Britain this makes up 17 million tons and approximately 20 billion Euros. Intellig more

• New Merck begins operations

  Merck & Co., Inc. outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation. The new Merck is a global health care leader aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and cre more

Publications Vaccines

• This Week in Science

  Simulating Foam Formation | Defense and Counter-Defense | Building Better Vaccines | A Phase for Fano | Making Metamaterials | Dust in the Clouds | Setting the Pace | Identical and Still Different | Infections Against Infection | Of Mice and Markets | Creating Unstable Atomic Orbitals | bZIPping Thr more

• Immunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance

  Recent advances in immunotherapy have demonstrated that single agent vaccines can be effective when given as primary prevention before exposure to the causative agent, and partially effective in some patients with existing cancer. However, as tumors develop and progress, tumor‐induced immune suppr more

• Dendritic cell immunotherapy

  The U.S. Food and Drug Administration's approval of the first cell‐based immunotherapy has rejuvenated interest in the field. Early clinical trials have established the ability of dendritic cell (DC) immunotherapy to exploit a patient's own immune system to induce antitumor immune responses. Howev more

Websites Vaccines